tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Belite Bio upgraded to Outperform from Neutral at Mizuho
PremiumThe FlyBelite Bio upgraded to Outperform from Neutral at Mizuho
22d ago
Belite Bio TBA Spot Secondary; price range $150.00-$154.00
Premium
The Fly
Belite Bio TBA Spot Secondary; price range $150.00-$154.00
23d ago
Belite Bio Reports Increased Cash Reserves Amid Rising R&D Costs
Premium
Company Announcements
Belite Bio Reports Increased Cash Reserves Amid Rising R&D Costs
23d ago
Belite Bio price target raised to $185 from $98 at H.C. Wainwright
PremiumThe FlyBelite Bio price target raised to $185 from $98 at H.C. Wainwright
23d ago
Belite Bio Stock (BLTE) Jumps on Positive Phase 3 STGD1 Trial Data
Premium
Market News
Belite Bio Stock (BLTE) Jumps on Positive Phase 3 STGD1 Trial Data
23d ago
Belite Bio Reports Breakthrough Phase 3 Results for Stargardt Disease Treatment
Premium
Company Announcements
Belite Bio Reports Breakthrough Phase 3 Results for Stargardt Disease Treatment
23d ago
Astera initiated, Nasdaq upgraded: Wall Street’s top analyst calls
PremiumThe FlyAstera initiated, Nasdaq upgraded: Wall Street’s top analyst calls
1M ago
Belite Bio initiated with a Neutral at Mizuho
Premium
The Fly
Belite Bio initiated with a Neutral at Mizuho
1M ago
Promising Outlook for Belite Bio’s Tinlarebant Drives Buy Rating Amidst Strong Financial Position and Regulatory Support
Premium
Ratings
Promising Outlook for Belite Bio’s Tinlarebant Drives Buy Rating Amidst Strong Financial Position and Regulatory Support
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100